AC
SRPT icon

Aaron Cowen’s Sarepta Therapeutics SRPT Stock Holding History

Aaron Cowen’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Hold
17,888
– – 0.01% 93
2026
Q1 		$389K Hold
17,888
– – 0.01% 86
2025
Q4 		$385K Hold
17,888
– – 0.01% 90
2025
Q3 		$345K Hold
17,888
– – 0.01% 91
2025
Q2 		$306K Hold
17,888
– – 0.01% 94
2025
Q1 		$1.14M Hold
17,888
– – 0.04% 89
2024
Q4 		$2.18M Buy
+17,888
New +$2.19M 0.07% 75
2023
Q4 		– Sell
-6,058
Closed -$734K – 97
2023
Q3 		$734K Hold
6,058
– – 0.04% 81
2023
Q2 		$694K Buy
+6,058
New +$781K 0.04% 92

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Aaron Cowen's SRPT Position: Q2 2026 in Review

Aaron Cowen held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 17,888 shares worth $321K. The position accounts for 0.01% of the portfolio, ranked #93.

Aaron Cowen first reported a position in SRPT in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.18M in Q4 2024. 320 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Aaron Cowen held 17,888 shares of Sarepta Therapeutics worth $321K as of Q2 2026.
  • Aaron Cowen left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up 0.01% of Aaron Cowen's portfolio in Q2 2026, its #93 holding.
  • Aaron Cowen first reported a position in Sarepta Therapeutics in Q2 2023 and has held it in 9 quarters since.
  • Aaron Cowen's Sarepta Therapeutics position peaked at $2.18M in Q4 2024.
  • 320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.